Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Ratner

Showing results (41-50 of 106) with videos related to

Pageof 11
Sort By:
Nature Biotechnology|March 10, 2015
Shire bags NPS, including newly approved biologic for hypoparathyroidismMark Ratner
Nature Biotechnology|January 11, 2014
Genentech's glyco-engineered antibody to succeed RituxanMark Ratner
Nature Biotechnology|April 9, 2009
Pharma swept up in biogenerics gold rushMark Ratner
Nature Biotechnology|January 9, 2016
Off-the-shelf CAR-T therapy induces remission in child with ALLMark Ratner
Nature Biotechnology|January 10, 2015
IBM's Watson Group signs up genomics partnersMark Ratner
Nature Biotechnology|August 9, 2017
First multi-gene NGS diagnostic kit approvedMark Ratner
Nature Biotechnology|November 8, 2014
Landmark approvals in idiopathic pulmonary fibrosisMark Ratner
Nature Biotechnology|July 9, 2015
Alexion pays big for Synageva's rare disease drug candidateMark Ratner
Nature Biotechnology|December 9, 2010
Crossing the lineMark Ratner
Nature Biotechnology|July 9, 2014
Odds still favor Novartis heart failure drug SerelaxinMark Ratner
Pageof 11

Showing results (41-50 of 106) with videos related to

Sort By:
Pageof 11
Nature Biotechnology|March 10, 2015
Shire bags NPS, including newly approved biologic for hypoparathyroidismMark Ratner
Nature Biotechnology|January 11, 2014
Genentech's glyco-engineered antibody to succeed RituxanMark Ratner
Nature Biotechnology|April 9, 2009
Pharma swept up in biogenerics gold rushMark Ratner
Nature Biotechnology|January 9, 2016
Off-the-shelf CAR-T therapy induces remission in child with ALLMark Ratner
Nature Biotechnology|January 10, 2015
IBM's Watson Group signs up genomics partnersMark Ratner
Nature Biotechnology|August 9, 2017
First multi-gene NGS diagnostic kit approvedMark Ratner
Nature Biotechnology|November 8, 2014
Landmark approvals in idiopathic pulmonary fibrosisMark Ratner
Nature Biotechnology|July 9, 2015
Alexion pays big for Synageva's rare disease drug candidateMark Ratner
Nature Biotechnology|December 9, 2010
Crossing the lineMark Ratner
Nature Biotechnology|July 9, 2014
Odds still favor Novartis heart failure drug SerelaxinMark Ratner
Pageof 11